A recent study presented at the Alzheimer’s Association International Conference unveiled groundbreaking findings about solanezumab, an antibody treatment showing potential to slow the progression of Alzheimer’s Disease. The study demonstrated that solanezumab reduces amyloid protein clumps (plaques) in the brain through human trials, offering new hope for managing this challenging condition. What Is the Breakthrough […]
Read More… from Solanezumab & Alzheimer’s Disease: A Promising Step Forward